Home World News No Survival Benefit from Adding Adjuvant Chemotherapy to Endocrine Therapy in Older... World News No Survival Benefit from Adding Adjuvant Chemotherapy to Endocrine Therapy in Older Women with a Genomic Grade Index High-Risk ER-positive, HER2-negative Breast Cancer By Ogkologos - August 19, 2025 758 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ASTER 70s study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR FDA Grants Accelerated Approval to Melphalan Flufenamide for Relapsed or Refractory... April 20, 2021 Sex, intimacy and cancer – That Cancer Conversation April 28, 2023 NHS lung cancer patients in England to get early access to... September 9, 2021 Biomarkers of Pro-Inflammatory Response May Identifiy Cancer Patients at Risk of... November 21, 2020 Load more HOT NEWS A urine test for bladder cancer: What’s the latest? Cancer-impacted mother becomes Times Square billboard to help child come across... New Measures to Avoid Handling Errors with Leuprorelin Depot Medicines Fragment Analysis Is a More Reliable MET Exon 14 Screening Strategy...
